Skip Navigation

Salud: Enfermedades no infecciosas

Opiniones

  • Imprimir
  • Comentar

Ignoring hypertensive disease a travesty

Fuente: The Lancet

7 may 2008 | EN | 中文

Blood pressure reading

Taking blood pressure readings in Mexico

Flickr/KeyExpert

Blood pressure-related diseases kill eight million people a year, mostly in developing countries, yet no major health development fund, development bank or major bilateral aid donor has addressed the problem, according to a comment article in The Lancet.

Similarly, no major international drug company has offered material assistance, "despite gargantuan profits from the sales of blood-pressure-lowering drugs in high-income countries," say Stephen MacMahon and colleagues.

In Africa, there is not a single initiative to implement blood pressure control strategies, even though stroke is rapidly becoming a common cause of death and disability on the continent.

The authors attribute the "staggering inequality" in treatment access to the inability of primary care systems to provide continuing care and the shortsighted view of those who set international health priorities.

They describe the outdated hypertensive care available for huge numbers of people as "a travesty that cannot continue to be ignored".

Link to full article in The Lancet*

 

*Free registration is required to view this article.

AGREGUE SU COMENTARIO

Esta es su red: comparta sus opiniones sobre cualquiera de nuestros artículos agregando sus comentarios.

Usted debe registrarse para enviar un comentario o para escribir a un autor que haya aceptado recibir comentarios. Por favor entrarsuscribirse.

Todos los comentarios están sujetos a revisión. Nos reservamos el derecho de editar los comentarios que contengan un lenguaje inapropiado o inadecuado. SciDev.Net mantiene los derechos de autor de todo el material que se publica en el portal. Por favor lea las condiciones de uso para más detalles.

Todo el material de SciDev.Net se puede reproducir gratuitamente siempre que se de crédito a la fuente y al autor. Para más detalles ver Creative commons.

Volver Opiniones
Subir